SUSAN CONATY-BUCK: Open Payments
NPI 1407913197 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$453 in 5 payments from 5 companies in 2025. Trend: 2023 $474 · 2024 $515 · 2025 $453
Food & beverage: $453
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $122 |
| Astellas Pharma US Inc | 1 | $120 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $76 |
| GlaxoSmithKline, LLC. | 1 | $69 |
| Tactile Systems Technology Inc | 1 | $67 |
Products named: FASENRA, Veozah, JARDIANCE, NUCALA, Flexitouch Plus.
Industry payments across DE — which companies pay providers there.
